BANK OF MONTREAL /CAN/ - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2022$1,229,000
+1517.1%
13,190
+2135.6%
0.00%
Q1 2021$76,000
-25.5%
5900.0%0.00%
Q4 2020$102,000
+6.2%
5900.0%0.00%
Q3 2020$96,000
+15.7%
5900.0%0.00%
Q2 2020$83,000
+27.7%
5900.0%0.00%
Q1 2020$65,000
-77.0%
590
-70.8%
0.00%
Q4 2019$282,000
+41.7%
2,024
-2.1%
0.00%
Q3 2019$199,000
-14.6%
2,067
+2.1%
0.00%
Q2 2019$233,000
-41.8%
2,024
-40.4%
0.00%
Q1 2019$400,000
+93.2%
3,396
+2.7%
0.00%
Q4 2018$207,000
-11.5%
3,3080.0%0.00%
Q3 2018$234,000
+6.4%
3,3080.0%0.00%
Q2 2018$220,000
+1.9%
3,3080.0%0.00%
Q1 2018$216,000
+31.7%
3,308
-19.3%
0.00%
Q4 2017$164,000
+10.1%
4,0980.0%0.00%
Q3 2017$149,000
+18.3%
4,098
-9.6%
0.00%
Q2 2017$126,000
+125.0%
4,535
+127.4%
0.00%
Q1 2017$56,0001,9940.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2020
NameSharesValueWeighting ↓
RA Capital Management 7,387,900$1,177,557,00016.32%
Q Global Advisors, LLC 66,714$10,634,0008.85%
Ghost Tree Capital, LLC 120,000$19,127,0005.59%
Vivo Capital, LLC 760,606$121,233,0005.44%
Spyglass Capital Management LLC 1,378,887$219,781,0005.04%
Avoro Capital Advisors LLC 1,980,000$315,592,0004.96%
Eversept Partners, LP 445,203$70,960,9064.93%
Sofinnova Investments, Inc. 499,824$79,667,0004.72%
Eventide Asset Management 1,748,648$278,717,0003.68%
Baker Brothers Advisors 4,541,604$723,886,0003.18%
View complete list of ASCENDIS PHARMA A/S shareholders